REQUEST A DEMO
Total
USD $0.00
Search more companies

Zonepharma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores
Full name: Zonepharma S.A.S. Profile Updated: July 10, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Zonepharma S.A.S. is based in Colombia, with the head office in Cali. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on January 25, 2013. 4 (2023) employees currently work for Zonepharma S.A.S.. In 2022, the company reported a net sales revenue drop of 1.04%. During that time, Zonepharma S.A.S.’s total assets grew by 32.53%. The enterprise’s net profit margin decreased by 10.15% in 2022.

Headquarters
Av 9 Norte 24 N 12
Cali; Valle del Cauca;

Contact Details: Purchase the Zonepharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Zonepharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Zonepharma S.A.S. report to view the information.
Incorporation Date:
January 25, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Zonepharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-1.04%
Total operating revenue
-1.04%
Operating profit (EBIT)
-76.2%
Net Profit (Loss) for the Period
-94.69%
Total assets
32.53%
Total equity
2.76%
Operating Profit Margin (ROS)
-14.54%
Net Profit Margin
-10.15%
Return on Equity (ROE)
-49.35%
Quick Ratio
-0.94%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?